Neuropsychopharmacology Research Group

• Ruso-Julve F, Pombero A, Pilar-Cuellar F, García-Díaz N, García-López R, Juncal-Ruiz M, Castro E, Díaz A, Vázquez-Bourgon J, García-Blanco A, Garro-Martínez E, Pisonero H, Estirado A, Ayesa-Arriola R, López-Gimenez J, Mayor Jr F, Valdizán E, Meana JJ, González-Maeso J, Martinez S, Vaqué JP, Crespo-Facorro B  Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics Translational Psychiatry,  2019;  9(1):306
• Muguruza C, Redon B, Fois GR, Hurel I, Scocard A, Nguyen C, Stevens C, Soria-Gomez E, Varilh M, Cannich A, Daniault J, Busquets-Garcia A, Pelliccia T, Caillé S, Georges F, Marsicano G, Chaouloff F.  The motivation for exercise over palatable food is dictated by cannabinoid type-1 receptors JCI Insight,  2019;  4(5):e126190
• Diez-Alarcia R, Yáñez-Pérez V, Muneta-Arrate I, Arrasate S, Lete E, Meana JJ, González-Díaz H.  Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [(35)S]GTPγS Binding Assays ACS Chemical Neuroscience,  2019;  10,  4476 - 4491
• Honer WG, Ramos-Miguel A, Alamri J, Sawada K, Barr AM, Schneider JA, Bennett DA.  The synaptic pathology of cognitive life Dialogues in Clinical Neuroscience,  2019;  21(3),  271 - 279
• Morentin B, Callado LF.  Sudden cardiac death associated to substances of abuse and psychotropic drugs consumed by young people: A population study based on forensic autopsies Drug and Alcohol Dependence,  2019;  201,  23 - 28
• Liu SS, Pickens S, Burma NE, Ibarra-Lecue I, Yang H, Xue L, Cook C, Hakimian JK, Severino AL, Lueptow L, Komarek K, Taylor AMW, Olmstead MC, Carroll FI, Bass CE, Andrews AM, Walwyn W, Trang T, Evans CJ, Leslie FM, Cahill CM.  Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain Journal of Neuroscience,  2019;  39(21),  4162 - 4178
• Muguruza C, Morentin B, Meana JJ, Alexander SP, Callado LF.  Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia Journal of Psychopharmacology,  2019;  33(9),  1132 - 1140
• García-Bea A, Miranda-Azpiazu P, Muguruza C, Marmolejo-Martinez-Artesero S, Diez-Alarcia R, Gabilondo AM, Callado LF, Morentin B, González-Maeso J, Meana JJ.  Serotonin 5-HT(2A) receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via G(αi1)-proteins European Neuropsychopharmacology,  2019;  29(12),  1453 - 1463
• Horrillo I, Ortega JE, Diez-Alarcia R, Urigüen L, Meana JJ.  Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α(2)-adrenoceptors in the rat frontal cortex but not locus coeruleus Neuropharmacology,  2019;  158:107731
• Fullana MN, Ferrés-Coy A, Ortega JE, Ruiz-Bronchal E, Paz V, Meana JJ, Artigas F, Bortolozzi A.  Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression Molecular Neurobiology,  2019;  56,  3038 - 3052
• Erdozain AM, Brocos-Mosquera I, Gabilondo AM, Meana JJ, Callado LF.  Differential α(2A)- and α(2C)-adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex Journal of Psychopharmacology,  2019;  2,  244 - 249
• Mongrédien R, Erdozain AM, Dumas S, Cutando L, Del Moral AN, Puighermanal E, Rezai Amin S, Giros B, Valjent E, Meana JJ, Gautron S, Callado LF, Fabre V, Vialou V.  Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons Brain Structure and Function,  2019;  224,  1219 - 1244
• Odagaki Y, Kinoshita M, Ota T, Meana JJ, Callado LF, García-Sevilla JA.  Optimization and pharmacological characterization of receptor-mediated G(i/o) activation in postmortem human prefrontal cortex Basic & Clinical Pharmacology & Toxicology,  2019;  124,  649 - 659
• Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, Bobes J, Desco M, Fañanás L, González-Pinto A, Haro JM, Leza JC, Mckenna PJ, Meana JJ, Menchón JM, Micó JA, Palomo T, Pazos Á, Pérez V, Saiz-Ruiz J, Sanjuán J, Tabarés-Seisdedos R, Crespo-Facorro B, Casas M, Vilella E, Palao D, Olivares JM, Rodriguez-Jimenez R, Vieta E.  CIBERSAM: Ten years of collaborative translational research in mental disorders Revista de Psiquiatría y Salud Mental,  2019;  12,  1 - 8
• Griñán-Ferré C, Vasilopoulou F, Abás S, Rodríguez-Arévalo S, Bagán A, Sureda FX, Pérez B, Callado LF, García-Sevilla JA, García-Fuster MJ, Escolano C, Pallàs M.  Behavioral and Cognitive Improvement Induced by Novel Imidazoline I(2) Receptor Ligands in Female SAMP8 Mice Neurotherapeutics,  2019;  16,  416 - 431
• Ramos-Miguel A, Barakauskas V, Alamri J, Miyauchi M, Barr AM, Beasley CL, Rosoklija G, Mann JJ, Dwork AJ, Moradian A, Morin GB, Honer WG.  The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1 Neuroscience,  2019;  420,  97 - 111
• Ramos-Miguel A, Gicas K, Alamri J, Beasley CL, Dwork AJ, Mann JJ, Rosoklija G, Cai F, Song W, Barr AM, Honer WG.  Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain Neuroscience,  2019;  420,  112 - 128
• Blasco-Benito S, Moreno E, Seijo-Vila M, Tundidor I, Andradas C, Caffarel MM, Caro-Villalobos M, Urigüen L, Diez-Alarcia R, Moreno-Bueno G, Hernández L, Manso L, Homar-Ruano P, McCormick PJ, Bibic L, Bernadó-Morales C, Arribas J, Canals M, Casadó V, Canela EI, Guzmán M, Pérez-Gómez E, Sánchez C.  Therapeutic targeting of HER2-CB(2)R heteromers in HER2-positive breast cancer PNAS,  2019;  116,  3863 - 3872